Profile
Dhananjay Suresh, PhD, is a researcher within the Department of Radiology leading cancer research and developing the next generation of nanotherapeutics. His current research is focused on developing anti-cancer precision medicine using smart biomaterials, nanotechnology, pharmacological inhibitors and post-translational RNAi and CRISPR; and understanding cancer pathways to combat the generation of drug resistance using immunoassays and transcriptome sequencing.
He has more than 15 years of research expertise in the areas of polyol nanochemistry, nanofabrication, materials characterization, genetic engineering and developing bionanotechnologies. Dr. Suresh has published more than a dozen scientific articles in high-impact journals and been granted four patents in the field of nanosensors, drug delivery and gene targeting for cancer therapy. Additionally, he is an active peer-reviewer in several scientific journals in his field and is involved in proposing and writing scientific grants towards nanoparticle therapeutics and gene targeting.
Dr. Suresh's work gives specific emphasis to engineering applications and provides training in an interdisciplinary approach, encompassing bioengineering, nanoscience and molecular biology to provide efficient solutions and positive outcomes to current clinical challenges.
Academic Information
Research Interests
- Understanding Drug Resistant Oncogenic Pathways
- Delivering siRNA and mRNA In Vivo
- Developing CRISPR Nanotherapeutics
- Exploring Bio/Nano Interface Chemistry
- Engineering Smart Materials
Areas of Expertise
- Cancer Biology
- Gene Therapy
- Applied Nanotechnology
- Diagnostic Biosensors
Awards & Honors
- 2020, Patent contribution Achievement, Awarded by the Chancellor, Alexander N. Cartwright and the Vice Chancellor for Research and Economic Development, Mark McIntosh at the University of Missouri.
- 2017, Outstanding Ph.D. Awardee, Top student at the MU College of Engineering, Awarded by the Dean of College of Engineering and the Vice chancellor for Strategic Partnerships, Dr. Elizabeth Loboa at the University of Missouri
Honorary Memberships
- 2015, Alpha Epsilon Honor Society (MU Chapter), Invited and elected member
- 2022, Sigma Xi Honor Society (MU Chapter), Nominated
Publications
- Magnetic Iron Nanocubes Effectively Capture Epithelial and Mesenchymal Cancer Cells, ACS Omega, 5(37), 2372423735 (2020), doi.org/10.1021/acsomega.0c02699
- Systematic Evaluation of Protein-Based Nanoparticles for Stable Delivery of Small Interfering RNA, Journal of Biomedical Nanotechnology, 16, 1182–1194 (2020), doi.org/10.1166/jbn.2020.2953
- Developmental exposure to Silver nanoparticles leads to Long term Gut Dysbiosis and Neurobehavioral Alterations, Nature Scientific Reports, 11(1), 6558 - March 2021, doi.org/10.1038/s41598-021-85919-7
- Controlled Assembly of Gold and Albumin Nanoparticles to form Hybrid Multimeric Nanomaterials, Polymers for Advanced Technologies, 33(2), 566-575 - October 2021, doi.org/10.1002/pat.5538
- Wastewater Treatment Using Novel Magnetic Nanosponges, Water, 14, 3, 505, (2022), doi.org/10.3390/w14030505
- Engineering Biomolecular Systems: Controlling the Self-Assembly of Gelatin to form Ultra-Small Bioactive Nanomaterials, Bioactive Materials, 18, 321-336, (2022), doi.org/10.1016/j.bioactmat.2022.02.035